+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gadoterate Meglumine Market by Application (Cardiology, Musculoskeletal, Neurology), End User (Ambulatory Surgical Centers, Diagnostic Imaging Centers, Hospitals), Product Form, Field Strength - Global Forecast 2025-2030- Product Image
Gadoterate Meglumine Market by Application (Cardiology, Musculoskeletal, Neurology), End User (Ambulatory Surgical Centers, Diagnostic Imaging Centers, Hospitals), Product Form, Field Strength - Global Forecast 2025-2030- Product Image
New

Gadoterate Meglumine Market by Application (Cardiology, Musculoskeletal, Neurology), End User (Ambulatory Surgical Centers, Diagnostic Imaging Centers, Hospitals), Product Form, Field Strength - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6129143
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Exploring the Pivotal Role of Gadoterate Meglumine in Modern Diagnostic Imaging and the Emerging Dynamics Shaping Its Global Market Landscape

The introduction to this executive summary sets the stage for a nuanced exploration of gadoterate meglumine, a macrocyclic gadolinium-based contrast agent that has become indispensable in high-resolution magnetic resonance imaging. With its robust safety profile and versatile application across multiple clinical settings, this compound has maintained a vital role in enhancing diagnostic clarity, particularly in neurological and musculoskeletal assessments.

As diagnostic imaging continues to advance, stakeholders from healthcare providers to pharmaceutical innovators face the imperative of understanding evolving technological capabilities and shifting regulatory landscapes. This overview distills complex developments into a coherent narrative, guiding decision-makers through key drivers, market dynamics, and strategic imperatives.

By weaving together clinical adoption patterns, operational challenges, and emerging opportunities, the introduction provides a solid foundation for deep-dive analysis. Transitional insights will pave the way toward recognizing how reimbursement frameworks, competitive strategies, and patient-centric innovations converge to influence the future trajectory of gadoterate meglumine in the global imaging ecosystem.

Analyzing Recent Transformative Shifts in Imaging Technology Adoption Reimbursement Policies and Clinical Practices Impacting Gadoterate Meglumine

Recent years have witnessed transformative shifts in how gadoterate meglumine is integrated into clinical practice and healthcare workflows. Advancements in MRI scanner hardware and software are enabling higher-resolution images at reduced dosage, encouraging radiology departments to reevaluate contrast protocols for improved patient safety. Meanwhile, enhanced reimbursement guidelines in various jurisdictions have alleviated budgetary constraints, fostering broader adoption across both established medical centers and emerging outpatient facilities.

In parallel, the pharmaceutical industry is responding with process optimizations to secure supply chain resilience, ensuring consistent access to sterile formulations. Novel partnerships between imaging equipment manufacturers and contrast agent suppliers are driving co-development of integrated solutions designed to streamline workflow efficiencies. Additionally, robust real-world evidence studies are generating deeper insights into long-term safety profiles, bolstering clinician confidence and facilitating label expansions.

These convergent developments underscore a shift toward value-based imaging models, where efficacy, cost-effectiveness, and patient experience are measured in tandem. As a result, stakeholders are increasingly prioritizing integrated strategies that align clinical excellence with sustainable operational frameworks.

Examining the Cumulative Impact of New United States Tariffs on Raw Materials Manufacturing Costs Distribution Channels and Market Access Dynamics in 2025

The imposition of United States tariffs in 2025 has introduced multifaceted challenges for gadoterate meglumine manufacturers and distributors. Tariffs applied to key raw materials and intermediates have led to upward pressure on production costs, compelling firms to reassess sourcing strategies and optimize their manufacturing footprints. Concurrently, higher logistics expenses have extended through the supply chain, affecting inventory management practices and prompting a reevaluation of buffer stock levels.

In response, leading companies have accelerated supply diversification by entering into strategic agreements with alternative suppliers in tariff-exempt regions. These adjustments have helped mitigate financial strain and maintain consistent product availability. However, the need to reconfigure distribution agreements and renegotiate contracts with healthcare facilities has introduced complexity and required agile contract management capabilities.

Despite these headwinds, the market has demonstrated resilience through adaptive pricing structures and a renewed focus on operational efficiency. This period of recalibration highlights the importance of strategic flexibility in a volatile policy environment, reinforcing the imperative for continuous monitoring of trade regulations and proactive scenario planning.

Unveiling Deep Insights from Diverse Segmentations by Clinical Application End User Product Form and Magnetic Field Strength for Strategic Positioning

Diving into granular segmentation insights reveals distinct performance drivers across clinical and operational domains. Application-based variations show heightened demand in cardiology as imaging protocols evolve to include cardiac MRI, while neurology continues to leverage superior contrast resolution for lesion detection. Oncology applications are on an upward trajectory as precision medicine initiatives integrate advanced imaging biomarkers, and musculoskeletal centers capitalize on detailed soft tissue visualization.

From an end-user perspective, hospitals remain the cornerstone for high-volume utilization, yet ambulatory surgical centers are rapidly adopting contrast-enhanced protocols to support same-day procedures, driving incremental growth. Diagnostic imaging centers, driven by outpatient convenience and specialized expertise, are also expanding their contrast agent inventories to meet rising referral volumes.

Product form insights indicate a sustained preference for solution for injection delivery in high-throughput environments, though powder for injection formulations find favor in regions with challenging cold-chain logistics due to their extended shelf stability. Finally, field strength plays a pivotal role, as 1.5 T scanners continue to dominate emerging markets with cost-effective deployments, while 3 T platforms lead in academic and tertiary care institutions that demand ultra-high-resolution imaging. These segmentation perspectives provide a strategic blueprint for targeted commercialization and resource allocation.

Key Regional Insights Revealing How Americas Europe Middle East Africa and Asia-Pacific Markets Are Driving Divergent Growth Patterns

Regional performance patterns for gadoterate meglumine reflect divergent healthcare infrastructure maturity and regulatory environments. In the Americas, well-established reimbursement frameworks and advanced imaging networks support steady volume growth, particularly in large tertiary medical centers. Meanwhile, innovative financing models are catalyzing adoption within outpatient settings.

Europe, Middle East & Africa present a heterogeneous landscape, where pockets of strong demand coexist with regions facing budgetary constraints. Western Europe’s standardized healthcare protocols foster broad contrast agent utilization, whereas certain emerging markets in the Middle East & Africa are accelerating uptake through public-private partnerships and mobile imaging units.

Across Asia-Pacific, rapid hospital expansions in urban centers are complemented by increasing access to cutting-edge MRI technology. Government-supported health modernization programs are driving capital investments in diagnostic imaging, with a particular emphasis on oncology and neurology applications. Nonetheless, variable regulatory timelines and pricing controls in select countries require nuanced market entry strategies. Understanding these regional nuances is critical for aligning distribution networks and optimizing partner engagement to capture localized growth opportunities.

Strategic Company Profiles and Key Competitive Insights Highlighting Collaborations Innovations and Portfolio Differentiation in the Gadoterate Meglumine Arena

Leading stakeholders in the gadoterate meglumine space are pursuing distinctive strategies to consolidate their market positions. Major pharmaceutical manufacturers have deepened their portfolios through targeted acquisitions, bolstering their sterile fill-finish capabilities and expanding geographic reach. Collaboration agreements with imaging equipment producers have further cemented integrated value propositions, enabling bundled offerings that streamline procurement and training processes for healthcare providers.

Meanwhile, emerging players are differentiating through niche specialty formulations and localized production partnerships, catering to region-specific cold-chain requirements and regulatory frameworks. These alliances have facilitated quicker market approvals and agile responses to supply chain disruptions.

In parallel, companies are investing in real-world data platforms to capture longitudinal safety and efficacy metrics, leveraging these insights to support label expansions and payer negotiations. Digital engagement channels and educational initiatives are being ramped up to reinforce clinician confidence, while patient advocacy programs highlight contrast safety profiles and procedural benefits. Collectively, this competitive landscape is characterized by strategic collaborations, innovation in manufacturing practices, and a relentless focus on evidence-based differentiation.

Actionable Recommendations for Industry Leaders to Enhance Operational Efficiency Drive Adoption and Foster Sustainable Growth around Gadoterate Meglumine Assets

Industry leaders should prioritize flexible sourcing models that incorporate dual-sourcing agreements and periodic supplier audits to fortify supply chain resilience against trade policy fluctuations. Simultaneously, aligning contract structures with dynamic pricing frameworks will help maintain competitive offerings without eroding margins.

Investing in robust real-world evidence generation through collaborations with academic institutions will reinforce the clinical value narrative, underpinning reimbursement negotiations and potential label extensions. By integrating outcomes data into marketing strategies, organizations can articulate clear return-on-investment scenarios for healthcare systems.

Furthermore, co-development partnerships with MRI equipment vendors can create seamless workflow configurations, enhancing user experience and driving incremental contrast utilization. Tailored training programs for radiology teams will support protocol standardization and reinforce best practices in contrast administration.

Lastly, fostering regional partnerships and public-private collaborations will enable targeted market access strategies, especially in emerging economies. By leveraging localized expertise, companies can navigate regulatory complexities and capture untapped demand segments with precision.

Rigorous Research Methodology Combining Primary Expert Interviews Secondary Literature Analysis and Robust Data Triangulation to Ensure Comprehensive Insights

This research employs a hybrid methodology integrating primary insights from expert interviews with radiologists, pharmacologists, and procurement specialists, alongside extensive secondary literature reviews of peer-reviewed journals, regulatory filings, and industry publications. Data triangulation techniques were applied to reconcile information from diverse sources, ensuring consistency and robustness in key findings.

Quantitative analyses were conducted on clinical utilization rates, supply chain metrics, and regional regulatory timelines to identify correlation patterns and impact drivers. Comprehensive cross-validation protocols guaranteed the reliability of emerging trends and strategic imperatives.

Periodic methodological reviews with an advisory panel of subject matter experts facilitated refinement of research instruments and validated interpretative frameworks. Privacy and compliance standards were strictly adhered to when collecting and processing stakeholder inputs, maintaining confidentiality and data integrity throughout the study.

Concluding Observations on Emerging Trends Technological Advancements and Strategic Imperatives Shaping the Future Outlook of Gadoterate Meglumine Applications

In conclusion, gadoterate meglumine stands at the nexus of innovation and integration within the diagnostic imaging sector. Its superior safety profile, combined with evolving clinical applications and strategic partnerships, underpins sustained relevance in an increasingly competitive landscape.

Despite headwinds from policy shifts and logistical challenges, adaptive strategies focused on supply chain diversification, value-based evidence generation, and collaborative technology integration offer a clear path forward. Regional heterogeneity in market dynamics underscores the importance of tailored approaches to market access and stakeholder engagement.

Looking ahead, the synergy between advanced MRI platforms and contrast agent innovation will drive enhanced diagnostic precision and patient outcomes. Organizations that embrace flexible operational models and leverage data-driven insights will be best positioned to capitalize on emerging opportunities within the broader imaging ecosystem.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Cardiology
    • Musculoskeletal
    • Neurology
    • Oncology
  • End User
    • Ambulatory Surgical Centers
    • Diagnostic Imaging Centers
    • Hospitals
  • Product Form
    • Powder For Injection
    • Solution For Injection
  • Field Strength
    • 1.5 T
    • 3 T
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Bayer AG
  • Bracco Imaging S.p.A.
  • GE HealthCare Technologies, Inc.
  • Guerbet S.A.
  • Sagent Pharmaceuticals, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of macrocyclic gadoterate meglumine formulations due to lower gadolinium retention risks
5.2. Expansion of gadoterate meglumine usage in pediatric magnetic resonance imaging applications amid safety concerns
5.3. Growing focus on regulatory harmonization for gadolinium-based contrast agents to streamline market approvals
5.4. Integration of machine learning algorithms to optimize gadoterate meglumine dosing and image enhancement protocols
5.5. Strategic partnerships between diagnostic imaging centers and manufacturers to ensure consistent gadoterate meglumine supply
5.6. Price competition from emerging generic gadolinium agents driving innovative contracting models for gadoterate meglumine procurement
5.7. Investment in green chemistry initiatives to reduce environmental footprint of gadoterate meglumine manufacturing processes
5.8. Emerging clinical data supporting use of gadoterate meglumine in functional MRI for neurodegenerative disease diagnosis
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gadoterate Meglumine Market, by Application
8.1. Introduction
8.2. Cardiology
8.3. Musculoskeletal
8.4. Neurology
8.5. Oncology
9. Gadoterate Meglumine Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Diagnostic Imaging Centers
9.4. Hospitals
10. Gadoterate Meglumine Market, by Product Form
10.1. Introduction
10.2. Powder For Injection
10.3. Solution For Injection
11. Gadoterate Meglumine Market, by Field Strength
11.1. Introduction
11.2. 1.5 T
11.3. 3 T
12. Americas Gadoterate Meglumine Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Gadoterate Meglumine Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Gadoterate Meglumine Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Bayer AG
15.3.2. Bracco Imaging S.p.A.
15.3.3. GE HealthCare Technologies, Inc.
15.3.4. Guerbet S.A.
15.3.5. Sagent Pharmaceuticals, Inc.
16. ResearchAI17. ResearchStatistics18. ResearchContacts19. ResearchArticles20. Appendix
List of Figures
FIGURE 1. GADOTERATE MEGLUMINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS GADOTERATE MEGLUMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS GADOTERATE MEGLUMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES GADOTERATE MEGLUMINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES GADOTERATE MEGLUMINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GADOTERATE MEGLUMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GADOTERATE MEGLUMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GADOTERATE MEGLUMINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. GADOTERATE MEGLUMINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. GADOTERATE MEGLUMINE MARKET: RESEARCHAI
FIGURE 24. GADOTERATE MEGLUMINE MARKET: RESEARCHSTATISTICS
FIGURE 25. GADOTERATE MEGLUMINE MARKET: RESEARCHCONTACTS
FIGURE 26. GADOTERATE MEGLUMINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GADOTERATE MEGLUMINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY POWDER FOR INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY POWDER FOR INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY SOLUTION FOR INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY SOLUTION FOR INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY 1.5 T, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY 1.5 T, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY 3 T, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GADOTERATE MEGLUMINE MARKET SIZE, BY 3 T, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. AMERICAS GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 40. AMERICAS GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 41. AMERICAS GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 42. AMERICAS GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS GADOTERATE MEGLUMINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS GADOTERATE MEGLUMINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 49. UNITED STATES GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 50. UNITED STATES GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 51. UNITED STATES GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. UNITED STATES GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. UNITED STATES GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 54. UNITED STATES GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES GADOTERATE MEGLUMINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES GADOTERATE MEGLUMINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 59. CANADA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 60. CANADA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 61. CANADA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. CANADA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. CANADA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 64. CANADA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 65. CANADA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 66. CANADA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 67. MEXICO GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. MEXICO GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. MEXICO GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. MEXICO GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. MEXICO GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 72. MEXICO GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 73. MEXICO GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 74. MEXICO GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 75. BRAZIL GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. BRAZIL GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. BRAZIL GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. BRAZIL GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. BRAZIL GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 80. BRAZIL GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 81. BRAZIL GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 82. BRAZIL GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 83. ARGENTINA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. ARGENTINA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. ARGENTINA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. ARGENTINA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. ARGENTINA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 88. ARGENTINA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 89. ARGENTINA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 90. ARGENTINA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED KINGDOM GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. UNITED KINGDOM GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 106. UNITED KINGDOM GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 108. UNITED KINGDOM GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 109. GERMANY GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. GERMANY GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. GERMANY GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. GERMANY GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. GERMANY GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 114. GERMANY GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 115. GERMANY GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 116. GERMANY GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 117. FRANCE GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. FRANCE GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. FRANCE GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. FRANCE GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. FRANCE GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 122. FRANCE GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 123. FRANCE GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 124. FRANCE GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 125. RUSSIA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. RUSSIA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. RUSSIA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. RUSSIA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. RUSSIA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 130. RUSSIA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 131. RUSSIA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 132. RUSSIA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 133. ITALY GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. ITALY GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. ITALY GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. ITALY GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. ITALY GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 138. ITALY GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 139. ITALY GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 140. ITALY GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 141. SPAIN GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. SPAIN GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. SPAIN GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. SPAIN GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. SPAIN GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 146. SPAIN GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 147. SPAIN GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 148. SPAIN GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. SAUDI ARABIA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. SAUDI ARABIA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 162. SAUDI ARABIA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 164. SAUDI ARABIA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. SOUTH AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. SOUTH AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 170. SOUTH AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 172. SOUTH AFRICA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 173. DENMARK GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. DENMARK GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. DENMARK GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. DENMARK GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. DENMARK GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 178. DENMARK GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 179. DENMARK GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 180. DENMARK GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 181. NETHERLANDS GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. NETHERLANDS GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. NETHERLANDS GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. NETHERLANDS GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. NETHERLANDS GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 186. NETHERLANDS GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 187. NETHERLANDS GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 188. NETHERLANDS GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 189. QATAR GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. QATAR GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. QATAR GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. QATAR GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. QATAR GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 194. QATAR GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 195. QATAR GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 196. QATAR GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 197. FINLAND GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. FINLAND GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. FINLAND GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. FINLAND GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. FINLAND GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 202. FINLAND GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 203. FINLAND GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 204. FINLAND GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 205. SWEDEN GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. SWEDEN GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. SWEDEN GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. SWEDEN GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. SWEDEN GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 210. SWEDEN GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 211. SWEDEN GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 212. SWEDEN GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 213. NIGERIA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. NIGERIA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. NIGERIA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. NIGERIA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. NIGERIA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 218. NIGERIA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 219. NIGERIA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 220. NIGERIA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 221. EGYPT GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. EGYPT GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. EGYPT GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. EGYPT GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. EGYPT GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 226. EGYPT GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 227. EGYPT GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 228. EGYPT GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 229. TURKEY GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. TURKEY GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. TURKEY GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. TURKEY GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. TURKEY GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 234. TURKEY GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 235. TURKEY GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 236. TURKEY GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 237. ISRAEL GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. ISRAEL GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. ISRAEL GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. ISRAEL GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. ISRAEL GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 242. ISRAEL GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 243. ISRAEL GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 244. ISRAEL GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 245. NORWAY GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. NORWAY GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. NORWAY GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. NORWAY GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. NORWAY GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 250. NORWAY GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 251. NORWAY GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 252. NORWAY GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 253. POLAND GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. POLAND GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. POLAND GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. POLAND GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. POLAND GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 258. POLAND GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 259. POLAND GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 260. POLAND GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 261. SWITZERLAND GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. SWITZERLAND GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. SWITZERLAND GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. SWITZERLAND GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. SWITZERLAND GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 266. SWITZERLAND GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 267. SWITZERLAND GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 268. SWITZERLAND GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. ASIA-PACIFIC GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. ASIA-PACIFIC GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 274. ASIA-PACIFIC GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 276. ASIA-PACIFIC GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC GADOTERATE MEGLUMINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 278. ASIA-PACIFIC GADOTERATE MEGLUMINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 279. CHINA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. CHINA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. CHINA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. CHINA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. CHINA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 284. CHINA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 285. CHINA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 286. CHINA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 287. INDIA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. INDIA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. INDIA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. INDIA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. INDIA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 292. INDIA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 293. INDIA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 294. INDIA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 295. JAPAN GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. JAPAN GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. JAPAN GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. JAPAN GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. JAPAN GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 300. JAPAN GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 301. JAPAN GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 302. JAPAN GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 303. AUSTRALIA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. AUSTRALIA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. AUSTRALIA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. AUSTRALIA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. AUSTRALIA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 308. AUSTRALIA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 309. AUSTRALIA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 310. AUSTRALIA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 311. SOUTH KOREA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. SOUTH KOREA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. SOUTH KOREA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. SOUTH KOREA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. SOUTH KOREA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 316. SOUTH KOREA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 317. SOUTH KOREA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 318. SOUTH KOREA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 319. INDONESIA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. INDONESIA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. INDONESIA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. INDONESIA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. INDONESIA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 324. INDONESIA GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 325. INDONESIA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 326. INDONESIA GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 327. THAILAND GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. THAILAND GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. THAILAND GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. THAILAND GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. THAILAND GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 332. THAILAND GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 333. THAILAND GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 334. THAILAND GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 335. PHILIPPINES GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 336. PHILIPPINES GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 337. PHILIPPINES GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. PHILIPPINES GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. PHILIPPINES GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 340. PHILIPPINES GADOTERATE MEGLUMINE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 341. PHILIPPINES GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
TABLE 342. PHILIPPINES GADOTERATE MEGLUMINE MARKET SIZE, BY FIELD STRENGTH, 2025-2030 (USD MILLION)
TABLE 343. MALAYSIA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 344. MALAYSIA GADOTERATE MEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 345. MALAYSIA GADOTERATE MEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. MALAYSIA GADOTERATE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Gadoterate Meglumine Market report include:
  • Bayer AG
  • Bracco Imaging S.p.A.
  • GE HealthCare Technologies, Inc.
  • Guerbet S.A.
  • Sagent Pharmaceuticals, Inc.

Related Topics

Related Reports

Meglumine Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Image

Meglumine Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 106 Pages
  • Global
From
Flunixin Meglumine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Image

Flunixin Meglumine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 103 Pages
  • Global
From
Flunixin Meglumine (CAS 42461-84-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Flunixin Meglumine (CAS 42461-84-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Iodipamide Meglumine (CAS 3521-84-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Iodipamide Meglumine (CAS 3521-84-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Meglumine Diatrizoate (CAS 131-49-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Meglumine Diatrizoate (CAS 131-49-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.